Cargando…

Editorial: Liver diseases and programmed cell death

Detalles Bibliográficos
Autores principales:	Cao, Peng, Liang, Yongyi, Wang, Yi, Mao, Chao, Wang, Weijia, Li, Sha, Luo, Lianxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089301/ https://www.ncbi.nlm.nih.gov/pubmed/37056984 http://dx.doi.org/10.3389/fphar.2023.1182013

Ejemplares similares

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Editorial: Progress of programmed cell death in antitumor immunity
por: Yan, Fangfang, et al.
Publicado: (2023)

Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy
por: Shi, Jing-Fen, et al.
Publicado: (2023)

Molecular mechanisms of programmed cell death in methamphetamine-induced neuronal damage
por: Guo, Dongming, et al.
Publicado: (2022)

Editorial: Different cell death modes in cancer treatment
por: Bai, Zhaoshi, et al.
Publicado: (2023)

Programmed Cell Death Protein 1/Programmed Cell Death Protein Ligand 1 Immunosuppressants in Advanced Non-Small Cell Lung Cancer Research Progress in Treatment
por: Li, Feng, et al.
Publicado: (2022)

Editorial: Autophagy and Related Transcription Factors in Liver and Gut Diseases
por: Eid, Nabil, et al.
Publicado: (2020)

Editorial: Big data for biomedical research of inflammatory diseases
por: Mao, Jingxin, et al.
Publicado: (2023)

Editorial: Natural products targeting oxidative stress and cell death: Treatment potential in metabolic and cardiovascular diseases
por: Kosuru, Ramoji, et al.
Publicado: (2023)

Editorial: Exploration of genetic variation, drug response, and interactions between gastrointestinal disorders and other diseases
por: Tong, Shuangshuang, et al.
Publicado: (2023)

Gossypol Inhibits Non-small Cell Lung Cancer Cells Proliferation by Targeting EGFR(L858R/T790M)
por: Wang, Yuwei, et al.
Publicado: (2018)

Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy
por: Li, Songtao, et al.
Publicado: (2022)

Editorial: The roles of ion-induced cell death in cancer treatment: volume II
por: Zhang, Kui, et al.
Publicado: (2023)

Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment
por: Xia, Xianghou, et al.
Publicado: (2023)

Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix
por: Liu, Rongyu, et al.
Publicado: (2022)

Krukovine Suppresses KRAS-Mutated Lung Cancer Cell Growth and Proliferation by Inhibiting the RAF-ERK Pathway and Inactivating AKT Pathway
por: Lai, Huanling, et al.
Publicado: (2018)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
por: Li, Xiaohui, et al.
Publicado: (2022)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
por: Qiu, Qin, et al.
Publicado: (2020)

Transcriptome Analysis of Liver Cancer Cell Huh-7 Treated With Metformin
por: Li, Chun-Qing, et al.
Publicado: (2022)

Editorial: Natural products as potential therapies for non-alcoholic fatty liver disease
por: Ibrahim, Islam A. A. E. H., et al.
Publicado: (2023)

Ferroptosis as an emerging therapeutic target in liver diseases
por: Lu, Yuzhen, et al.
Publicado: (2023)

Chinese Herbal Medicine for Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Peng, Sihan, et al.
Publicado: (2022)

Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease
por: Wang, Xue-Kai, et al.
Publicado: (2021)

Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases
por: Wu, Baoming
Publicado: (2022)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
por: Blas-García, Ana, et al.
Publicado: (2022)

Editorial: Nonalcoholic fatty liver disease: From pathogenesis to phytomedicine based on omics technology
por: Ji, Guang, et al.
Publicado: (2022)

Editorial: Advances in the potential treatments of gastrointestinal and liver diseases: addressing the public health burden
por: Turcu-Stiolica, Adina, et al.
Publicado: (2023)

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease
por: Zou, Xiao, et al.
Publicado: (2023)

Editorial: Applications of Nanobiotechnology in Pharmacology
por: Qi, Baowen, et al.
Publicado: (2019)

Editorial: Bioactive substances-mediated targeted therapy of cardio-cerebrovascular diseases
por: Tong, Xiaoyong, et al.
Publicado: (2023)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Editorial: Biologically active products as therapeutic options for the treatment of cardiovascular diseases related to liver injury
por: Gasparotto Junior, Arquimedes, et al.
Publicado: (2022)

Programmed Cell Death in Liver Fibrosis
por: Gao, Ruoyu, et al.
Publicado: (2023)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis
por: Wang, Xuewen, et al.
Publicado: (2020)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
por: Gao, Song, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qc5dl6cv5616fh1ri1f31rie8n